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CASE PRESENTATION
A Case of Disseminated Nocardia beijingensis Manifesting as 
Subcutaneous and CNS Nocardiosis in an Immunocompetent 
Patient
Scott Cathcart, MD,1 Patricia Stogsdill, MD,2 Rebecca Bell3
1Department of Internal Medicine, Maine Medical Center, Portland, ME, 2Department of Infectious Diseases, Maine Medical 
Center, Portland, ME, 3Tufts Medical School, Boston, MA
Introduction:  Nocardiosis is an uncommon infection, typically encountered in immunocompromised patients. Only 5 
cases have been reported in the United States. We present a case of disseminated Nocardia beijingensis 
involving the lung, subcutaneous tissue, and central nervous system of an immunocompetent patient.
Clinical Findings:  A 60-year-old immunocompetent male with no significant medical history presented to our hospital after 
a complicated medical course, beginning with vague respiratory complaints. His initial work-up revealed 
a large mass of unclear etiology in the right upper lung. A month later, he had a syncopal episode and 
then developed focal neurologic deficits.
 Sputum cultures obtained after the patient’s syncopal episode grew gram-positive rods. Results of a 
computed tomography of the chest showed a new 17-mm subcutaneous mass. The mass was biopsied, 
which revealed gram-positive rods with partial acid-fast staining. Week later, results of magnetic 
resonance imaging of his brain showed multiple enhancing lesions with vasogenic edema scattered 
throughout. A tissue culture from his chest mass was sent to the Mayo Clinic and ultimately grew 
Nocardia beijingensis. The patient was started on the appropriate antibiotic therapy and has made 
significant clinical improvement.
Conclusions:  Though Nocardia is often associated with an immunocompromised state, it can also occur in patients 
with pulmonary findings and evidence of disseminated disease, particularly central nervous system 
manifestations, regardless of immune status. A high index of suspicion is needed, as definitive diagnosis 
often takes weeks due to the slow-growing nature of Nocardia species.
Keywords:  Nocardia beijingensis, disseminated, neurologic, CNS
CASE PRESENTATION
The patient was a pleasant, albeit anxious, 
gentleman with a greater than 20-year history of 
right-side neck pain following a remote trauma, as 
well as post-traumatic stress disorder. In March 
2019, the patient was seen by his primary care 
physician after 2 months of progressive cough 
with associated wheezing, fevers, sweats, and 
chest/back pain. The results of his chest x-ray 
were negative, but the results of his follow-up CT 
(computed tomography) revealed a large mass in 
his right apical lung (Figure 1).
Three days after the CT, the patient was evaluated 
in the emergency department (ED), where his 
health care provider was initially concerned about 
malignancy vs tuberculosis. The results of a 
T-spot were negative. He was given amoxacillin-
clavulanate for post-obstructive pneumonia. 
Two days later, the results of his follow-up PET 
(positron emission tomography) scan showed a 
6- to 7-cm mass in his right upper lobe that was 
strongly positive for fluorodeoxyglucose. This result 
suggested a primary lung malignancy/Pancoast 
tumor, especially in the context of fevers, night 
sweats, and weight loss. Interestingly, he showed 
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a lack of mediastinal adenopathy. The results of 
a subsequent CT-guided biopsy revealed chronic 
inflammatory changes consistent with pneumonia 
and no evidence of neoplasm. He failed to improve 
with amoxacillin-clavulanate. He was transitioned to 
levofloxacin and a prednisone taper due to concern 
for bronchiolitis obliterans organizing pneumonia, 
and he continued his 3-week course of antibiotics. 
This treatment appeared to provide some benefit, 
but his condition deteriorated when antibiotics were 
stopped. A bronchoscopy was performed 1 month 
after his initial presentation to the ED, but the results 
were negative for Pneumocystis jiroveci, as were 
the results following fungal silver stain, cytology for 
malignancy, and acid-fast staining and culture. He 
was given a 5-day steroid burst after the procedure, 
again without improvement.
He presented to the ED again after a syncopal 
episode several days after the bronchoscopy with 
a leukocytosis of 30,000 (90% polymorphonuclear), 
fevers to 102ºF, and complaints of intermittent 
hemoptysis. The patient was given broad-spectrum 
antibiotics (meropenem and vancomycin) as his 
presentation was again thought to be due to a 
bacterial process, and he had responded positively 
to antibiotics in the past. Sputum cultures eventually 
grew gram-positive rods. The results of a CT of the 
chest during this stay revealed a stable infiltrate in 
the right upper lung with new tree-in-bud opacities 
and mild ground-glass opacities, consistent with 
multifocal pneumonia. The results also noted a new 
17-mm subcutaneous mass on his chest at the level 
of the sternum. Results from a biopsy of this lesion 
revealed gram-positive rods with partial acid-fast 
staining, concerning for Actinomyces or Nocardia, 
similar to those identified in the sputum cultures 
obtained on his admission. The culture was sent 
to the Mayo Clinic for speciation and susceptibility 
testing. Given the patient’s immunocompetent state 
(he was HIV-negative and lacked other comorbid 
conditions), Actinomyces was favored over 
Nocardia, and he was given IV penicillin in addition 
to meropenem. This treatment was further tailored 
to oral trimethoprim-sulfamethoxazole (800/160 
mg, 2 times daily) and penicillin V (500 mg, 4 times 
daily) before discharging him on hospital day 10. He 
was discharged with plans for indefinite antibiotics 
and follow-up with his pulmonologist. During this 
admission, an extensive work-up for possible 
fungal etiologies was performed. The results were 
negative for Cryptococcus, coccidioidomycosis, 
and histoplasmosis. A CT of his head was also 
conducted to further evaluate the patient’s syncope. 
The result of the CT showed 2 discrete focal 
hypodensities within the right and left parietal gray-
white junctions with surrounding edema, which 
were concerning for metastatic disease vs focal 
areas of hemorrhage. This finding was not worked 
up further.
The patient initially did well on this regimen. At a 
follow-up appointment with his pulmonologist a 
week after discharge, he reported feeling much 
better, his fevers and hemoptysis resolved, and he 
noticed a decrease in his night sweats. However, 
his cough persisted. He subsequently developed 
issues with balance and double-vision, particularly 
with an extreme upward gaze, which prompted his 
return to the ED a week later. The results of an MRI 
of his brain revealed “multiple enhancing lesions 
with vasogenic edema scattered throughout,” which 
was consistent with an infectious process in his 
central nervous system (CNS), with disseminated 
Nocardia the most likely organism (Figure 2).
He was given IV meropenem, IV trimethoprim-
sulfamethoxazole, and steroids, and then 
transferred to our facility for a higher level of care. 
A transesophageal echo was obtained to rule out 
endocarditis. An MRI of his spine was performed 
to look for osteomyelitis. Results of imaging of his 
cervical spine raised the possibility of osteomyelitis 
with abnormal prevertebral edema at the level of 
C5/C6, which was not seen in the results of an 
Figure 1. Computed tomography of the chest revealing 
large mass in right apical lung.
2
Journal of Maine Medical Center, Vol. 2 [2020], Iss. 2, Art. 13
https://knowledgeconnection.mainehealth.org/jmmc/vol2/iss2/13
DOI: 10.46804/2641-2225.1057
MRI obtained several months earlier. A peripherally 
inserted central catheter line was placed, and the 
patient was discharged on 6 weeks of IV antibiotics 
(trimethoprim-sulfamethoxazole and meropenem) 
and close follow-up with infectious diseases. 
Culture data returned from the Mayo Clinic, which 
revealed Nocardia beijingensis. After completing 5 
weeks of IV antibiotics, he was transitioned to per 
os trimethoprim-sulfamethoxazole with a plan to 
continue therapy for an additional 12 months.
Two months after his diagnosis (almost 4 months 
after his initial ED presentation), the patient ceased 
to experience night sweats or cough, and he began 
to regain strength and daily functioning. However, 
his posterior neck pain and radicular symptoms 
down his right side persisted. The results of a follow-
up chest CT at this time showed that the mass-like 
consolidation in the right upper lobe had nearly 
resolved. The results of an MRI of his brain 1 month 
later revealed a marked interval decrease in the 
size and number of enhancing parenchymal lesions 
when compared to results from 2 months earlier. 
The adjacent vasogenic edema also significantly 
decreased. The results of an MRI of the spine at the 
same time was consistent with ongoing Nocardia 
osteomyelitis, with decreased prevertebral edema 
and no evidence of discitis. The patient continued 
to have double-vision at the periphery as a result of 
these resolving brain lesions. Five months later, the 
results of another MRI of the brain showed a further 
decrease in size and signal intensity of the focal 
areas of signal hyperintensity, as well as resolution 
of signal enhancement, compared to prior imaging.
DISCUSSION
The genus Nocardia is a ubiquitous group of gram-
positive bacilli found in the environment, primarily 
in soil, but also in decomposing organic matter 
and both fresh water and saltwater. These bacteria 
are thought to play a role in the soil ecosystem 
and can cause significant disease in susceptible 
hosts.1,2 More than 50 species have been identified. 
Of these, the most common are the Nocardia 
asteroides complex, which have been reorganized 
into several different species based on their 
differing drug susceptibilities.1 Nocardia species 
are typically opportunistic organisms, but up to one-
third of patients are immunocompetent. Pulmonary 
nocardiosis is the most common presentation, 
as inhalation is the primary route of inoculation, 
and is often difficult to differentiate from fungal 
and mycobacterial infections. Extrapulmonary 
manifestations due to disseminated disease are 
common. The most common sites for dissemination 
include the CNS, skin and subcutaneous tissues, 
eyes, kidneys, joints, bones, and the heart. The 
CNS is affected in approximately one-third of 
all cases. Primary cutaneous and soft-tissue 
nocardial lesions can occur following traumatic 
skin injuries contaminated with soil, typically in 
immunocompetent hosts.1,3
In 2001, Nocardia beijingensis was first identified 
after being isolated from a mud sample taken from 
a sewage ditch in Beijing.2 In 2004, the first human 
infections were reported in Thailand and Japan.4 In 
2014, the first case of Nocardia beijingensis was 
reported in the United States. The case involved 
an immunocompetent patient at the Mayo Clinic 
Florida.5 Since 2014, only 5 additional cases 
of Nocardia beijingensis have been reported in 
the Western hemisphere. Of these, 3 occurred 
in immunocompetent hosts, and all 3 were in 
Florida.6-10 The most recent report by Chauhan, in 
2019, was the only case in the United States that 
involved the CNS.9 Ours is the second reported 
case of CNS nocardiosis in the United States, and 
the first with multiple simultaneous manifestations of 
disseminated nocardiosis. Our immunocompetent 
Figure 2. T2-weighted magnetic resonance imaging 
of the brain with multiple enhancing lesions and 
vasogenic edema
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patient developed primary pulmonary disease, 
which spread to the subcutaneous tissue overlying 
his sternum and to his brain. The diagnosis was 
ultimately made based on a tissue biopsy of his 
sternal lesion, and the CNS lesions were assumed 
to be of the same etiology.
Pulmonary nocardiosis typically presents as 
subacute pneumonia, with symptoms developing 
over days or weeks. Less common is an acute 
presentation with symptoms such as dyspnea, 
pleuritic pain, and hemoptysis.11 CNS nocardiosis 
is also variable in presentation, most often 
manifesting as focal neurologic deficits, headache, 
fever, and seizures. CNS nocardiosis appears as 
ring-enhancing lesions on brain imaging and is 
often initially misdiagnosed as tumor or abscess.12
Clinical diagnosis is difficult, given the varied and 
nonspecific presentations. The current diagnostic 
gold standard is a positive microbiological culture 
from a site of active infection. The results of most 
cultures are positive within 2 to 7 days, but they can 
take up to 2 to 3 weeks due to the bacteria’s slow 
growth.13 Testing by polymerase chain reaction is 
currently being evaluated but not generally available 
in practice.14 Both Nocardia and Actinomyces fail 
to stain with classic, non-modified acid-fast stains. 
However, Nocardia partially stains with acid-fast 
staining when modified techniques are used. This 
approach is useful for differentiating Nocardia 
from Actinomyces, another gram-positive, thin, 
branching, filamentous bacilli. Actinomyces may 
present similarly to Nocardia, but the results of 
modified acid-fast staining are classically negative 
for Actinomyces.15 This fact suggests that the initial 
staining results from the chest lesion should have 
been interpreted as more concerning for Nocardia 
than Actinomyces. However, there have been 
rare reports of Actinomyces staining positive with 
modified acid-fast staining.16 Another useful test to 
differentiate these 2 organisms is anaerobic culture. 
Actinomyces species will grow under anaerobic 
conditions, but Nocardia are obligate aerobes.15 In 
our case, an anaerobic culture of the chest lesion 
may have helped providers arrive at the correct 
diagnosis sooner.
First-line treatment for nocardiosis is sulfonamide 
therapy, with trimethoprim-sulfamethoxazole 
being the most commonly used agent. Several 
alternative choices are effective against most 
Nocardia species, including amikacin, imipenem, 
meropenem, ceftriaxone, cefotaxime, minocycline, 
moxifloxacin, levofloxacin, linezolid, tigecycline, 
and amoxicillin-clavulanic acid. In most cases, 
combination therapy should be used to enhance 
activity and decrease the possibility of developing 
antibiotic resistance. In treating CNS disease, 
antibiotics with favorable CNS penetration should 
be selected. Sulfonamides, alone or combined 
with trimethoprim, are most effective and typically 
used first-line for at least 1 year. Combining 
minocycline, imipenem, or aminoglycoside with a 
third-generation cephalosporin may also be used 
as alternative therapies.17
This case illustrates that a diagnostic dilemma 
can arise when a rare condition presents in an 
atypical population. Our patient presented with an 
unusual infection and no clear exposure history. 
Furthermore, the organism is more commonly seen 
in immunocompromised hosts and is less likely to 
present in immunocompetent patients. This detail 
clearly affected the interpretation of the culture data 
obtained from the patient’s chest mass, delaying 
his appropriate treatment. While Nocardia is less 
common, it is important to remember that more 
than 30% of patients infected with Nocardia are 
immunocompetent. Finally, multiple tests can help 
differentiate Actinomyces from Nocardia when the 
diagnosis is unclear and should be used when 
possible. 
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